Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas
Crossref DOI link: https://doi.org/10.1007/s11060-014-1710-0
Published Online: 2015-01-08
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goutagny, Stéphane
Raymond, Eric
Esposito-Farese, Marina
Trunet, Stéphanie
Mawrin, Christian
Bernardeschi, Daniele
Larroque, Béatrice
Sterkers, Olivier
Giovannini, Marco
Kalamarides, Michel
Text and Data Mining valid from 2015-01-08